Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Pooled Post Hoc Analyses Through 1 Year of Two Phase 3 Studies

被引：0
|
作者：
Coates, Laura C. [1 ]
Ramirez, Julio [2 ]
McGonagle, Dennis [3 ]
Aydin, Sibel [4 ]
Zimmermann, Miriam [5 ]
Nantel, Francois [6 ]
Shawi, May [7 ]
Rampakakis, Emmanouil [8 ,9 ]
Nash, Peter [10 ,11 ]
Mease, Philip [12 ,13 ]
机构：
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England
[2] Hosp Clin Barcelona, Dept Rheumatol, Arthrit Unit, Barcelona, Spain
[3] Univ Leeds, Leeds Biomed Res Ctr, Leeds, England
[4] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] Janssen Sci Affairs LLC, Immunol, Zug, Switzerland
[6] Nantel Medsci Consult, Montreal, PQ, Canada
[7] Janssen Pharmaceut Co Johnson Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA
[8] McGill Univ, Dept Pediat, Montreal, PQ, Canada
[9] JSS Med Res, Montreal, PQ, Canada
[10] Griffith Univ, Maroochydore, Australia
[11] Univ Queensland, Maroochydore, Australia
[12] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[13] Univ Washington, Seattle, WA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB152 / AB152
页数：1
相关论文
共 50 条
  • [1] EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY
    Coates, L.
    Ramirez, J.
    Mcgonagle, D.
    Aydin, S.
    Zimmermann, M.
    Nantel, F.
    Shawi, M.
    Rampakakis, E.
    Nash, P.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1137 - 1137
  • [2] Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Post Hoc Analysis Through 2 Years of a Phase 3 Study
    Coates, Laura
    Ramirez, Julio
    McGonagle, Dennis
    Aydin, Sibel
    Zimmermann, Miriam
    Nantel, Francois
    Shawi, May
    Rampakakis, Emmanouil
    Nash, Peter
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4187 - 4189
  • [3] Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials
    Curtis, Jeffrey R.
    Deodhar, Atul
    Soriano, Enrique R.
    Rampakakis, Emmanouil
    Shawi, May
    Shiff, Natalie J.
    Han, Chenglong
    Tillett, William
    Gladman, Dafna D.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1501 - 1517
  • [4] Early Clinical Improvement as Predictor of Long-term Health-Related Quality of Life in Psoriatic Arthritis Patients Treated with Guselkumab: Post Hoc Analysis Through 2 Years of a Phase 3 Study
    McInnes, Iain B.
    Soriano, Enrique R.
    Tam, Lai-Shan
    Shiff, Natalie
    Shawi, May
    Rampakakis, Emmanouil
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4184 - 4187
  • [5] Early Clinical Improvement as Predictor of Long-Term Health-Related Quality of Life in Psoriatic Arthritis Patients Treated With Guselkumab: Post Hoc Analysis Through 2 Years of a Phase 3 Study
    McInnes, Iain
    Soriano, Enrique
    Tam, Lai-Shan
    Bessette, Louis
    Shiff, Natalie
    Shawi, May
    Rampakakis, Emmanouil
    Curtis, Jeffrey
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 81 - 82
  • [6] Efficacy of Guselkumab in Early-Onset and Late-Onset Psoriatic Arthritis: Post Hoc Pooled Analyses of Two Phase 3 Randomized Controlled Trials in Patients with Active PsA
    Soriano, Enrique
    Kishimoto, Mitsumasa
    Rampakakis, Emmanouil
    Nantel, Francois
    Shawi, May
    Lavie, Frederic
    Mease, Philip J.
    Gladman, Dafna
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2834 - 2837
  • [7] POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR
    Ritchlin, C. T.
    Rahman, P.
    Helliwell, P.
    Boehncke, W. H.
    Mcinnes, I.
    Gottlieb, A. B.
    Kafka, S.
    Kollmeier, A.
    Hsia, E. C.
    Xu, X. L.
    Shawi, M.
    Sheng, S.
    Agarwal, P.
    Zhou, B.
    Ramachandran, P.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1300 - 1301
  • [8] Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis Through 1 Year
    Ritchlin, Christopher
    Rahman, Proton
    Helliwell, Philip
    Boehncke, Wolf-Henning
    McInnes, Iain
    Gottlieb, Alice
    Kafka, Shelly
    Kollmeier, Alexa
    Hsia, Elizabeth
    Xu, Xie
    Shawi, May
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Ramachandran, Paraneedharan
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY
    Mcinnes, I.
    Soriano, E.
    Tam, L. S.
    Shiff, N.
    Shawi, M.
    Rampakakis, E.
    Curtis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1765 - 1766
  • [10] Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies
    McGonagle, Dennis
    McInnes, Iain B.
    Deodhar, Atul
    Schett, Georg
    Shawi, May
    Kafka, Shelly
    Karyekar, Chetan S.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Ritchlin, Christopher T.
    Rahman, Proton
    Mease, Philip J.
    RHEUMATOLOGY, 2021, 60 (11) : 5337 - 5350
12345